Clinical pharmacology and therapeutics
-
Clin. Pharmacol. Ther. · Aug 2017
LetterRegulatory Consequences of "Brexit" for the Development of Medicinal Products.
The United Kingdom voted in a referendum in June 2016 to leave the European Union (EU) after 45 years of membership. Among the many political, social, and scientific consequences are those for the regulation of health care products. ⋯ The European Medicines Agency (EMA), which is currently located in London, will move elsewhere in Europe. The pharmaceutical industry will reassess its commitment to the UK health scene.